Brief: US says Athira Pharma to pay $4 mln to settle allegations of scientific research misconduct

Jan 6 (Reuters) - U.S. Justice Department:
    * U.S. JUSTICE DEPARTMENT SAYS ATHIRA PHARMA INC. AGREES TO
PAY
$4M TO SETTLE FALSE CLAIMS ACT ALLEGATIONS RELATED TO SCIENTIFIC
RESEARCH MISCONDUCT


Further company coverage:  ATHA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on LeonaBio

See all news